April 28 (Reuters) - Watson Pharmaceuticals Inc:
* Confirms Rapamune patent challenge
* Says has been sued by Pfizer Wyeth pharmaceuticals related to ANDA
for sirolimus tablets
* Believes it may be 'first applicant' to file anda for the 1 mg and 2 mg
generic version of Rapamune
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Confirms Rapamune patent challenge
* Says has been sued by Pfizer Wyeth pharmaceuticals related to ANDA
for sirolimus tablets
* Believes it may be 'first applicant' to file anda for the 1 mg and 2 mg
generic version of Rapamune
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.